McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better.
For businesses across healthcare, being healthy means having what you need to operate more efficiently and improve the lives of patients. McKesson champions those working on the front lines of healthcare by helping them deliver better care at lower costs. We see the industry the way no one else can: comprehensively. And we’re confident in the impact we create because of that view.
To learn more about how we help customers, read our blog http://www.mckesson.com/blog/
Cardinal Health is a distributor of pharmaceuticals and specialty products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; a provider of performance and data solutions; and a global manufacturer and distributor of medical and laboratory products. Our company’s customer-centric focus drives continuous improvement and leads to innovative solutions that improve people’s lives every day.
Disclaimer: LinkedIn is a third-party site unaffiliated with Cardinal Health. Cardinal Health is not responsible for the privacy or security policies or practices on LinkedIn or on any of the third-party websites that we may link to through LinkedIn. You should carefully review the privacy and security practices of LinkedIn and linked third-party websites. We do not necessarily endorse any information found here nor are we responsible for the accuracy of any information, opinions, claims, or advice found here or shared here by our followers. By posting content, ideas, or pictures, you grant Cardinal Health a non-exclusive, royalty-free, perpetual, and worldwide license to use your content and any images posted by you, including the rights to copy, distribute, transmit, display, reproduce, edit, translate, and reformat, and incorporate into a collective work. Cardinal Health reserves all rights relating to the company's LinkedIn account, including removing postings and prohibiting individuals from participating on the page.
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Medical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint